SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories submits earnings call intimation

29 Apr 2026 Evaluate
Neuland Laboratories has informed that the company will announce its results for the fourth quarter and full year ended March 31, 2026 on May 12, 2026. The results will also be made available on the website of the Company, www.neulandlabs.com. Following the announcement, the management of the Company will host an Earnings Call on May 12, 2026 at 17:30 hrs.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

16203.05 67.30 (0.42%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×